Wayne D. McGrath

FDA investigator · also recorded as Once Wayne D. McGrath, Ae Wayne D. McGrath

Appears on 33 documents from 2018 to 2025, most often at sites in India. Most often cites production record review (21 CFR 211.192).

33
Documents on file
4.8
Observations per 483
2018
First seen
2025
Most recent

What they cite most

From 164 observations

Activity by year

2018: 2, 2019: 3, 2020: 2, 2021: 6, 2022: 6, 2023: 6, 2024: 6, 2025: 2

Where

India 8 · Missouri 8 · Canada 2 · China 2 · Germany 2 · Iowa 2

Is Wayne D. McGrath coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

33 documents, newest first
FirmOpen
483 NATCO Pharma LimitedJun 19, 2025 · Rangareddy, India
483 Apot ex IncMay 9, 2025 · Richmond Hill, Canada
483 ACS DOBFAR SPAOct 29, 2024 · Castellalto, Italy
483 Indoco Remedies LimitedJul 26, 2024 · Vasco Da Gama, Goa, India
483 Unichem Laboratories LimitedJul 15, 2024 · Pilerne, India
483 SRIKEM LABORATORIES PRIVATE LIMITEDMay 31, 2024 · Navi Mumbai, India
483 Mylan Laboratories LimitedMay 24, 2024 · Nashik, India

About this profile

What does Wayne D. McGrath inspect?

Wayne D. McGrath appears on 33 documents on file covering 33 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Wayne D. McGrath is dated Jun 19, 2025.